No Data
No Data
Quest Diagnostics, Southwest Airlines Rise; Simulations Plus Falls, Wednesday, 7/3/2024
OMERS Selling LifeLabs to Quest Diagnostics in Deal Valued at $1.35B
Nephron Adjusts Price Target on Quest Diagnostics to $155 From $152
Quest Diagnostics (DGX) has an average outperform rating and a price target range of $136 to $160, according to analysts polled by Capital IQ. Price: 138.77, Change: +2.13, Percent Change: +1.56
Express News | Quest Diagnostics Shares up About 2% After Co Expands Into Canada With Nearly $1 Bln Lifelabs Deal
Quest Diagnostics' Strategic Expansion Into Canadian Market
Quest Diagnostics to Buy LifeLabs From OMERS
08:49 AM EDT, 07/03/2024 (MT Newswires) -- Quest Diagnostics to Buy LifeLabs From OMERS